{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Although none of the 50 abstracts explicitly mention or characterize the function of LOC102723407, a careful appraisal of the literature provided reveals a landscape of interconnected cellular processes—involving apoptosis, epigenetic regulation, DNA repair fidelity, chromatin dynamics, and immune cell differentiation—in which an uncharacterized gene such as LOC102723407 might eventually be implicated. For example, several studies demonstrate the importance of anti‐apoptotic signaling and BCL2 regulation in leukemias and lymphomas (for example"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": ", while other reports emphasize epigenetic control mediated by histone methyltransferases such as EZH2 and KMT2D in B‐cell development and malignant transformation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "9"}]}, {"type": "t", "text": " In addition, a number of studies have dissected key mechanisms in the maintenance of genomic stability and precise DNA repair—processes critical for both normal lymphocyte function and prevention of oncogenic rearrangements."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "15"}]}, {"type": "t", "text": " Finally, regulation of immune cell differentiation and effective transcriptional programming in B cells—as exemplified by studies on ZAP‐70, IL‐21 receptor signaling, and BATF—underpins both normal immune responses and the pathogenesis of hematologic malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "16", "end_ref": "19"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In this context, LOC102723407—currently annotated only as an uncharacterized locus—might intersect with one or more of these critical pathways. Its genomic location, expression patterns, or potential protein–protein interactions could eventually reveal a role in modulating apoptotic balance, chromatin structure, or DNA repair machinery in hematopoietic cells. However, as the current body of evidence does not provide direct functional insights into LOC102723407, further dedicated studies will be required to delineate its molecular activity and potential relevance as a biomarker or therapeutic target in malignancies or other diseases.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Andrew W Roberts, Matthew S Davids, John M Pagel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "N Engl J Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1056/NEJMoa1513257"}], "href": "https://doi.org/10.1056/NEJMoa1513257"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26639348"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26639348"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Thorsten Zenz, Barbara Eichhorst, Raymonde Busch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TP53 mutation and survival in chronic lymphocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2009.27.8762"}], "href": "https://doi.org/10.1200/JCO.2009.27.8762"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20697090"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20697090"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Stephan Stilgenbauer, Andrea Schnaiter, Peter Paschka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2014-01-546150"}], "href": "https://doi.org/10.1182/blood-2014-01-546150"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24652989"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24652989"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Mohammed Z H Farooqui, Janet Valdez, Sabrina Martyr, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lancet Oncol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S1470-2045(14)71182-9"}], "href": "https://doi.org/10.1016/S1470-2045(14"}, {"type": "t", "text": "71182-9) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25555420"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25555420"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ryan D Morin, Nathalie A Johnson, Tesa M Severson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.518"}], "href": "https://doi.org/10.1038/ng.518"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20081860"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20081860"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Wendy Béguelin, Relja Popovic, Matt Teater, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2013.04.011"}], "href": "https://doi.org/10.1016/j.ccr.2013.04.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23680150"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23680150"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "I-Hsin Su, Ashwin Basavaraj, Andrew N Krutchinsky, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Immunol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ni876"}], "href": "https://doi.org/10.1038/ni876"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12496962"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12496962"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Jiyuan Zhang, David Dominguez-Sola, Shafinaz Hussein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.3940"}], "href": "https://doi.org/10.1038/nm.3940"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26366712"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26366712"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ana Ortega-Molina, Isaac W Boss, Andres Canela, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.3943"}], "href": "https://doi.org/10.1038/nm.3943"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26366710"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26366710"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Samuel F Bunting, Elsa Callén, Nancy Wong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2010.03.012"}], "href": "https://doi.org/10.1016/j.cell.2010.03.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20362325"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20362325"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "J Ross Chapman, Patricia Barral, Jean-Baptiste Vannier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2013.01.002"}], "href": "https://doi.org/10.1016/j.molcel.2013.01.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23333305"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23333305"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Guotai Xu, J Ross Chapman, Inger Brandsma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "REV7 counteracts DNA double-strand break resection and affects PARP inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature14328"}], "href": "https://doi.org/10.1038/nature14328"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25799992"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25799992"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Craig H Bassing, Heikyung Suh, David O Ferguson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0092-8674(03)00566-x"}], "href": "https://doi.org/10.1016/s0092-8674(03"}, {"type": "t", "text": "00566-x) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12914700"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12914700"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Michela Di Virgilio, Elsa Callen, Arito Yamane, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1230624"}], "href": "https://doi.org/10.1126/science.1230624"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23306439"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23306439"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Cameron S Osborne, Lyubomira Chakalova, Jennifer A Mitchell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myc dynamically and preferentially relocates to a transcription factory occupied by Igh."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pbio.0050192"}], "href": "https://doi.org/10.1371/journal.pbio.0050192"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17622196"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17622196"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Adrian Wiestner, Andreas Rosenwald, Todd S Barry, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2002-10-3306"}], "href": "https://doi.org/10.1182/blood-2002-10-3306"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12595313"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12595313"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Michelle A Linterman, Laura Beaton, Di Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20091738"}], "href": "https://doi.org/10.1084/jem.20091738"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20142429"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20142429"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Danielle T Avery, Elissa K Deenick, Cindy S Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20091706"}], "href": "https://doi.org/10.1084/jem.20091706"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20048285"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20048285"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Wataru Ise, Masako Kohyama, Barbara U Schraml, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Immunol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ni.2037"}], "href": "https://doi.org/10.1038/ni.2037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21572431"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21572431"}]}]}]}